Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -0.43% | 688.87 | 2.6% | $679.29m | |
| MRNA | Moderna, Inc. | 0.15% | 118.25 | 0.0% | $616.94m | |
| AMGN | Amgen, Inc. | -1.32% | 225.40 | 1.4% | $605.62m | |
| BIIB | Biogen, Inc. | 1.03% | 267.00 | 1.8% | $554.62m | |
| GILD | Gilead Sciences, Inc. | -2.19% | 61.69 | 1.0% | $514.54m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.11% | 289.54 | 1.9% | $401.56m | |
| ILMN | Illumina, Inc. | -1.56% | 190.79 | 3.2% | $338.76m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 4.40% | 4.27 | 0.7% | $298.49m | |
| SAVA | Cassava Sciences, Inc. | -2.90% | 41.82 | 0.0% | $189.63m | |
| BNTX | BioNTech SE | 0.96% | 134.88 | 0.0% | $112.19m | |
| NVAX | Novavax, Inc. | -1.99% | 18.20 | 75.6% | $84.03m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.34% | 84.77 | 4.2% | $82.56m | |
| NRBO | NeuroBo Pharmaceuticals, Inc. | 9.35% | 13.69 | 0.0% | $78.90m | |
| PRTA | Prothena Corp. Plc | 1.95% | 60.63 | 13.8% | $78.20m | |
| CRSP | CRISPR Therapeutics AG | 1.33% | 65.35 | 0.6% | $76.10m |
Company Profile
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ failure and cancer. GCS-100, the Company's lead product candidate, is a first-in-class inhibitor of galectin-3, a novel molecular target implicated in chronic organ failure and cancer. LJPC-501, the Company's second product candidate, is a natural peptide for the treatment of the hepatorenal syndrome.